Literature DB >> 1693183

The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors.

D Ray1, S Culine, A Tavitain, F Moreau-Gachelin.   

Abstract

Spi-1 is a putative proto-oncogene involved in murine virus-induced acute erythroleukemias. We report here the identification of the human homologue of Spi-1 and its expression in normal and tumorigenic human tissues. Characterization of cDNA clones revealed that the human Spi-1 gene encodes a 216 amino acids protein showing 85% identity with the murine counterpart. By sequencing genomic clones, five exons were identified. To investigate the possible role of Spi-1 gene in human cancers, we studied its expression in a panel of human tumors by Northern blot analysis. Spi-1 expression was detected in all the tumors examined. There was no noticeable evidence of messenger RNA alteration as compared to normal tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693183

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Do lampreys have lymphocytes? The Spi evidence.

Authors:  S Shintani; J Terzic; A Sato; M Saraga-Babic; C O'hUigin; H Tichy; J Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

Review 3.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

4.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

5.  Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.

Authors:  M S Petrovick; S W Hiebert; A D Friedman; C J Hetherington; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.

Authors:  Yu Zhu; Luo Lu; Chun Qiao; Yi Shan; Huapeng Li; Sixuan Qian; Ming Hong; Huihui Zhao; Jianyong Li; Zhongfa Yang; Yaoyu Chen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

7.  Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor.

Authors:  C Perez; E Coeffier; F Moreau-Gachelin; J Wietzerbin; P D Benech
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro.

Authors:  Yu-Zhong Wang; Xun-Gang Feng; Qi-Guang Shi; Yan-Lei Hao; Yan Yang; Ai-Mei Zhang; Qing-Xia Kong
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor.

Authors:  Biaoyang Lin; Jun Wang; Xu Hong; Xiaowei Yan; Daehee Hwang; Ji-Hoon Cho; Danielle Yi; Angelita G Utleg; Xuefeng Fang; Dustin E Schones; Keji Zhao; Gilbert S Omenn; Leroy Hood
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

10.  Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1.

Authors:  D Ray; R Bosselut; J Ghysdael; M G Mattei; A Tavitian; F Moreau-Gachelin
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.